SPONSOR
Amgen
Total Trials
4
Recruiting
4
Phases
Phase 4, Phase 3, Phase 2
Conditions studied: Antineutrophil Cytoplasmic Antibody-associated VasculitisAtherosclerotic Cardiovascular DiseaseOverweightObesityObstructive Sleep ApneaSystemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
Obesity
NCT06570798 Phase 2
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Systemic Lupus Erythematosus